Literature DB >> 6251946

Relationships between seizure activity and cyclic nucleotide levels in brain.

J A Ferrendelli, A C Blank, R A Gross.   

Abstract

The effects of pentylenetetrazol on behavior, EEG activity and regional CNS levels of cyclic AMP (cAMP) and cyclic GMP (cGMP) in mice and guinea pigs were studied. Pentylenetetrazol increased cGMP levels in all regions of brain examined (cerebral cortex, hippocampus, striatum and cerebellum) and increased cAMP levels in all regions except striatum. cGMP levels were increased by both sub-convulsant and convulsant doses of pentylenetetrazol. In contrast, cAMP levels were elevated only by concentrations of pentylenetetrazol that produced clinically evident seizures or epileptiform EEG activity. These data indicate that increases in CNS cGMP levels produced by epileptogenic stimuli can occur independently of seizure discharges, whereas accumulation of cAMP requires and is secondary to seizure activity. In conjunction with results of other studies, these data support the hypothesis that cGMP may have a role in seizure genesis and/or propagation, whereas cAMP may be involved in processes that attenuate or terminate seizures.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251946     DOI: 10.1016/0006-8993(80)91097-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Differential effects of cocaine-induced seizures and lethality on M(1)-like muscarinic and dopaminergic D (1)- and D (2)-like binding receptors in mice brain.

Authors:  Danielle Silveira Macêdo; Silvânia Maria Mendes Vasconcelos; Manoel Andrade-Neto; Marta Maria França Fonteles; Lissiana Magna Vasconcelos Aguiar; Glauce Socorro Barros Viana; Francisca Cléa Florençode Sousa
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

2.  Immunohistochemical localization of guanylate cyclase within neurons of rat brain.

Authors:  M A Ariano; J A Lewicki; H J Brandwein; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

Review 3.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

4.  Elevation of brain cyclic nucleotides during acute dieldrin exposure.

Authors:  R M Joy; S N Giri; M J Schiedt
Journal:  Bull Environ Contam Toxicol       Date:  1982-05       Impact factor: 2.151

5.  Alcohol Withdrawal Increases Protein Kinase A Activity in the Rat Inferior Colliculus.

Authors:  Luli R Akinfiresoye; Clive Miranda; David M Lovinger; Prosper N'Gouemo
Journal:  Alcohol Clin Exp Res       Date:  2016-09-26       Impact factor: 3.455

6.  Heme-coordinating inhibitors of neuronal nitric oxide synthase. Iron-thioether coordination is stabilized by hydrophobic contacts without increased inhibitor potency.

Authors:  Jeffrey D Martell; Huiying Li; Tzanko Doukov; Pavel Martásek; Linda J Roman; Michael Soltis; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2010-01-20       Impact factor: 15.419

7.  Modulation of the cAMP signaling pathway after traumatic brain injury.

Authors:  Coleen M Atkins; Anthony A Oliva; Ofelia F Alonso; Damien D Pearse; Helen M Bramlett; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2007-08-29       Impact factor: 5.330

8.  Differences in ME-LI and VIP-LI in discrete brain regions of seizure-naive and seizure-experienced El mice.

Authors:  T Kanamatsu; S Hirano
Journal:  Neurochem Res       Date:  1988-10       Impact factor: 3.996

9.  In the hippocampus in vivo, nitric oxide does not appear to function as an endogenous antiepileptic agent.

Authors:  J L Stringer; F Erden
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

Review 10.  The cerebellum and epilepsy.

Authors:  Martha L Streng; Esther Krook-Magnuson
Journal:  Epilepsy Behav       Date:  2020-02-05       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.